Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT)

被引:2
作者
Kaptanoglu, Asli Feride
Uncu, Murat
Ozyurt, Selcuk
Hincal, Evren
机构
[1] Near East Univ Hosp, Dept Dermatol, Lefkosa, North Cyprus, Turkey
[2] Near East Univ Hosp, Dept Biochem, Lefkosa, North Cyprus, Turkey
[3] Ataturk Res & Educ Hosp, Dept Dermatol, Izmir, Turkey
[4] Near East Univ, Fac Arts & Sci, Dept Math, Lefkosa, North Cyprus, Turkey
关键词
isotretinoin; side effects; prothrombin time; activated partial thromboplastin time; coagulation; surgery; ROUTINE BLOOD-TESTS; ACNE-VULGARIS; HEMOPHILIA-A; THROMBOCYTOPENIA; THERAPY; FIBRINOLYSIS; GUIDELINES;
D O I
10.3109/09546634.2011.652063
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Patients with severe acne may need elective/urgent surgical interventions during treatment with isotretinoin and it is critical for the surgeon to consider the possible effects of this medication on coagulation systems. The aim of this study is to determine the changes in prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT) during isotretinoin treatment. PT, aPTT, and INR values of 51 severe acne patients were evaluated during routine pretreatment biochemical analysis. Only patients with normal values were included in the study. The results of before and after 1 month treatment were compared statistically. There were no statistically significant change in mean alanine aminotranferease (ALT), aspartate aminotransferase (AST), PT, and INR values after treatment. A significant increase in aPTT was detected. The INR values, which are more trusted and safe, showed no difference. Isotretinoin seems to have no effect on these coagulation parameters.
引用
收藏
页码:272 / 274
页数:3
相关论文
共 18 条
[1]   Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? [J].
Alcalay, J ;
Landau, M ;
Zucker, A .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2001, 12 (01) :9-12
[2]   A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris [J].
Altman, RS ;
Altman, LJ ;
Altman, JS .
DERMATOLOGY, 2002, 204 (03) :232-235
[3]   TRANSIENT DYSFIBRINOGENEMIA AND ACUTE-PANCREATITIS DURING ISOTRETINOIN THERAPY [J].
AUROUSSEAU, MH ;
LEVACHER, S ;
BENETON, C ;
BLAISE, M ;
POURRIAT, JL .
REVUE DE MEDECINE INTERNE, 1995, 16 (08) :622-625
[4]  
BACK O, 1995, ACTA DERM-VENEREOL, V75, P290
[5]   Oral isotretinoin and haemophilia A [J].
Bettoli, V ;
Pizzigoni, S ;
Vasina, S ;
Mancino, A ;
Virgili, A .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (06) :718-720
[6]   Preventing and Managing the Side Effects of Isotretinoin [J].
Brelsford, Megan ;
Beute, Trisha Clarke .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2008, 27 (03) :197-206
[7]   EXACERBATION OF BLEEDING TENDENCY IN A PATIENT WITH HEMOPHILIA-A, DURING TREATMENT WITH ISOTRETINOIN [J].
DOOTSON, GM ;
KEIDAN, J ;
ANDERSON, JAR .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (02) :186-187
[8]  
DOOTSON GM, 1995, BRIT J DERMATOL, V133, P66
[9]   Is it necessary to have routine blood tests in patients treated with isotretinoin? [J].
Ertam, Ilgen ;
Alper, Sibel ;
Unal, Idil .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2006, 17 (04) :214-216
[10]  
HESDORFFER CS, 1986, S AFR MED J, V70, P705